Delivery Order SPE2DB20D9127-SPE2DB24FPPV0

Award Date 2/2/24
Potential Completion Date 2/26/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,124.80 contract is for the delivery of 1,000 unit vials of the specialized medication Kcentra by August 27, 2024. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,284.80, is for the delivery of 1,000 unit vials of the drug Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $78,466.75 contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which enables the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,714.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the specialty pharmaceutical product Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,448.32 contract is for the delivery of 1,000 unit vials of the medication Kcentra by February 14, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,866.56 contract was awarded by the Defense Logistics Agency (DLA) on August 19, 2024 and has an ultimate completion date of September 10, 2024. The award is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,732.80 and has an ultimate completion date of September 26, 2024. The contract is for the delivery of Kcentra 500 unit vials, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery...
This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $71,947.68 firm fixed-price contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra, with a period of performance through May 2, 2024. The award is issued by the Defense Logistics Agency (DLA), a defense agency that provides supplies and services to the U.S. military. This delivery order is placed against DMS Pharmaceutical Group's...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,311.36, is for the supply of 1,000 unit vials of the medication Kcentra. The delivery order was issued under a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC...
The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the pharmaceutical product KCENTRA with a firm fixed price of $15,944.80 and a completion date of March 27, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, number 4600082013 under the SPE2DB program, that DMS Pharmaceutical...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB24FPPV0
    Delivery Order

This is a firm fixed-price delivery order worth $22,800.00 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the biologic drug Kcentra by February 26, 2024. This delivery order falls under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue firm fixed-price orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 2/27/25, 1:23 PM